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ABSTRACT 
Introduction: The incidence of cancer of the esophagus/GE junction is dramatically increasing, 
but continues to have a dismal prognosis. Esophagectomy provides the best opportunity for long-
term cure, but is hampered by increased rates of perioperative morbidity.. We reviewed our large 
institutional experience to evaluate the impact of postoperative complications on the long-term 
survival of patients undergoing resection for curative intent. 
Methods: We identified 237 patients who underwent esophagogastrectomy,  with curative 
intent, for cancer between 1994 and 2008.  Complications were graded using the previously 
published Clavien scale. Survival was calculated using Kaplan-Meier methodology and survival 
curves were compared using log-rank tests. Mulivariate analysis was performed with continuous 
and categorical variables as predictors of survival, and examined with logistic regression and 
odds ratio confidence intervals.  
Results: There were twelve (5%) perioperative deaths. The average age of all patients was 62, 
and the majority (82%) was male. Complication grade did not significantly affect long-term 
survival, although patients with grade IV (serious) complications did have a decreased survival 
(p=0.15). Predictors of survival showed that the minimally invasive type esophagectomy 
(p=0.0004) and pathologic stage (p=0.0007) were determining factors. There was a significant 
difference in overall survival among patients who experienced pneumonia (p=.00016) and 
respiratory complications (p=.00040), but this was not significant on multivariate analysis. 
Conclusion: In this single institution series, we found that major perioperative morbidity did not 
have a negative impact on long-term survival which is different than previous series. The impact 
of tumor characteristics at time of resection on long-term survival is of most importance.   
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INTRODUCTION 
Esophageal cancer is a devastating disease with a grim prognosis.  The National Cancer 
Institute’s Surveillance Epidemiology and End Results (SEER) reports 5-year survival rates for 
localized esophageal cancer to be 37.4%, regional to be 18.8%, and distant to be 3.2%.1 Surgery 
remains the treatment of choice for prolonged survival and the chance for a definitive cure. 
However, esophagectomy is a complicated procedure often associated with increased risks of 
postoperative morbidity and mortality.  
Known factors that improve postoperative prognosis are early stage at resection, R0 
resection and complete response to neoadjuvant chemoradiotherapy. However, there is still 
debate on the impact of postoperative complications and associated morbidity on long-term 
survival. In 2004, a retrospective analysis of 510 patients who underwent esophagogastrectomy 
for esophagus or gastroesophageal junction carcinoma at Memorial Sloan-Kettering Cancer 
Center2 reported that patients with no technical complications had better overall survival than 
patients with technical complications. A 2009 retrospective analysis of 150 patients who 
underwent transthoracic esophagectomy for curative intent at Leuven University Hospitals3 
reported a strong correlation between severity of complications and time to tumor recurrence.  A 
2008 retrospective analysis by Lagarde et al, of 191 patients, who died from tumor recurrence 4 
concluded that postoperative complications are independently associated with a shorter time 
interval to death due to recurrence.  
On the other hand, in 2006, a retrospective analysis of 522 patients who underwent 
resection of thoracic esophagus and gastroesophageal carcinoma at Veneto Region’s Center for 
Esophageal Diseases5 reported that long term prognosis is dependent exclusively on the tumor 
characteristics and not affected by surgical complications.  Similarly, a 2006 retrospective 
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analysis of 434 patients who underwent resection of squamous cell carcinoma of the esophagus 
at University of Hong Kong Medical Centre6 reported no effect on long term survival in patients 
with surgical complications.  
There are also conflicting reports on the effect of respiratory complications, the most 
common being pneumonia, on long-term prognosis.  Examining 38 patients who developed 
pneumonia amongst 118 patients total, a 2004 study 7 reported that pneumonia not only affected 
perioperative mortality, but also long term survival.  This is in contrast with a study in 20118, 
which did not find any significant difference in disease free survival as a result of respiratory 
complications of atelectasis, pneumonia, or acute respiratory distress syndrome.  
To further examine this important question, we reviewed our large single-institution 
experience to determine the impact of perioperative complications on long-term survival in 
patients with cancers of the esophagus and GE junction who have undergone esophagectomy. 
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PATIENTS AND METHODS 
Using an IRB-approved institutional esophagectomy database, we identified patients who 
underwent esophagectomy for invasive adenocarcinoma or squamous cell carcinoma of the 
esophagus, gastroesophageal junction, or stomach cardia at Thomas Jefferson University 
Hospital (TJUH) between January 1994 and December 2008. There were 237 patients who had 
undergone surgery with curative intent. In many cases, we performed a retrospective review of 
the medical records of patients in order to retrieve specific data such as neo-adjuvant treatments, 
surgical data, histologic and pathologic data of the resected specimen, postoperative surgical and 
medical complications, adjuvant therapy, recurrence, and survival.  
Operative procedure 
The type of esophageal resection was assigned according to the operative note and was 
performed at discretion of the operating surgeon. The type of esophagectomy performed 
included:  Ivor-Lewis (laparotomy and right thoracotomy), transhiatal (laparotomy and neck 
incision), 3-hole (laparotomy, thoracotomy, and neck incision), and minimally invasive 
esophagectomy (MIE), which includes laparoscopy and video-assisted thoracoscopy (VATS), 
laparoscopic transhiatal, and thoracoscopic 3-hole.  
Pathology 
All patients had squamous cell carcinoma or adenocarcinoma of the esophagus, 
gastroesophageal junction, or gastric cardia. Patients were staged according to the 6th Edition of 
the AJCC staging system9. Resections were defined as: complete removal of tumor with 
microscopic examination of margins showing no tumor cells (R0), microscopic examination of 
margins showing tumor cells (R1), and macroscopic examination of margins showing tumor 
cells (R2). Patients who underwent R2 resection (non-curative intent) were eliminated from 
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survival analysis. A pathologic complete response (pCR) was defined as a patient who did not 
have any viable tumor in the specimen at the time of surgical resection. 
Complications 
We graded postoperative technical and medical complications related to the operation 
using a modification of the Clavien classification10. Complications were classified into 6 grades 
(Table 1).  In brief, Grade 0 patients did not experience any complications. Grade 1 was assigned 
to patients who experienced complications that did not result in a change of the postoperative 
course.  Complications that required pharmacological treatment, blood transfusion, or total 
parenteral nutrition were assigned Grade 2.  Any complication that required invasive or 
radiological intervention was assigned Grade 3, Patients who experienced life-threatening 
complications requiring ICU stay were given a Grade 4 complication – 4a for single organ 
dysfunction and 4b for multi-organ dysfunction.   Perioperative mortality was assigned Grade 5.  
Perioperative complications and morbidity were recorded during the initial hospital stay – from 
day of surgery to discharge. Complications resulting in patients being readmitted within 30 days 
of surgery were also considered. Perioperative mortality was considered to include any patient 
who died within 90 days of surgery or during the postoperative stay for their esophagectomy. 
Survival and Statistical Analysis 
Survival data were obtained from the medical records and the Social Security Death 
Index. Survival (months) was calculated from the date of surgery. Patients were followed for 
survival for at least one year post-operation. Survival analysis was calculated using Kaplan-
Meier methodology and curves were compared using log-rank tests. Continuous variables (length 
of stay) were compared using Student’s t-test, with a p value <0.05 being considered significant. 
Categorical variables were compared using chi-square. A multivariate analysis was performed 
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with continuous and categorical variables as predictors of survival, and examined with logistic 
regression and odds ratio confidence intervals. The following complications were included in the 
multivariate analysis—pneumonia, respiratory failure, anastomotic leakage, and wound 
infection. 
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RESULTS 
Patient characteristics 
 We identified all patients who underwent an operation with curative intent for invasive 
squamous cell carcinoma or adenocarcinoma (n=237). The average age of patients was 62 (range 
32-86). The majority of patients were men (82.3% versus 17.7%, M/F 4.6:1). There were 140 
(59.1%) patients that were nonsmokers, while 97 (40.9%) had an active smoking history. The 
majority of patients received neoadjuvant chemoradiation treatment (n=155, 65.4%), 
predominantly 5-fluorouracil and cisplatinum with 45Gy external beam radiation. Out of the 155 
patients who received neoadjuvant treatment, 33 (21.3%) patients had a pCR. Of the 237 
procedures (Table 2), the most common were transhiatal (n=110, 46.4%) and Ivor-Lewis (n=58, 
24.5%). There were also 26 (11.0%) were minimally invasive esophagectomy procedures. 
Adenocarcinoma was present in 201 tumors (84.8%). The median length of postoperative stay 
(LOS) was 12 days (range 1-116).  
 Negative margin resection was achieved in 212 patients (89.5%), and R1 resection   
in 16 patients (6.8%).  The majority of tumors (Table 2) were located at the gastroesophageal 
junction (n=106, 44.7%) and distal esophagus (n=80, 33.8%). The most frequent pathologic 
stage was stage II (n=84, 35.4%). 
Postoperative Complications (Table 3) 
There were 100 (42.2%) patients who had an unremarkable postoperative course 
(complication grade 0). Twelve patients (5.1%) had perioperative mortalities (Grade 5). The 
majority, 57.8% (n=137) of patients had postoperative complications (Grades 1-4). Among 
patients with complications, 9.6% (n=12) were Grade 1, 42.4% (n=53) were Grade 2, 20% 
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(n=25) were Grade 3, and 28% (n=35) were Grade 4. The median survival among the 225 
patients (excluding 12 patients with perioperative mortalities) was 20.8 months.  
Patients were divided into three classes, those with no complications (Group 1—Grade 0, 
n=99, 42.0%), those with minor complications (Group 2—Grade 1-2, n=65, 27.5%), and those 
with major complications and mortality (Group 3—Grades 3-5, n=72, 30.5%). Patient 
characteristics (age, gender, smoking history, histology, tumor location, pathologic stage, 
induction therapy, operative procedures) between the two groups were not found to be 
significantly different (Table 4). There was no significant difference in completeness of resection 
between the two groups. However, the median LOS (p < 0.0001) was found to be significantly 
different between patients in Group 1 (12 days), Group 2 (13.1 days), and Group 3 (29 days).  
The most common complications (Table 5) were respiratory failure requiring intubation 
(n=35, 14.8%), supraventricular arrhythmia (n=34, 14.3%), anastomotic leakage (n=32, 13.5%), 
pleural effusion requiring thoracocentesis or a chest tube (n=30, 12.7%), wound infection (n=27, 
11.4%), and pneumonia (n=26, 11%).  
Overall survival (Figure 1) was compared for patients with no (grade 0), minor 
complications (Grade 1, 2) and major complications and mortality (Grade 3, 4 and 5). There was 
not a significant difference in overall survival by complication grade (p=0.095), even though 
patients with major complications did fare slightly worse (especially in the first 5 years). In the 
bivariate analysis, the survival was worst for patients with grade 4 complications, however this 
was not statistically significant (p=0.15).  
However, when examining specific complications (Table 6), we found a significant 
increase in length of stay for patients who had postoperative pneumonia, respiratory failure, or 
anastomotic leakage. There was a significant difference in overall survival (p=0.0002) among 
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patients who developed pneumonia (n=26, 15.0 months) and patients who did not (n=210, 27.8 
months), as well as among patients who developed respiratory failure (n=42, 15.8 months) and 
patients who did not (n=194, 28.7 months). The impact of pneumonia (p=0.24) and respiratory 
failure (p=0.15) was lost on multivariate analysis as a predictor of survival. Multivariable 
analysis (Table 7) on the predictors of survival showed that type of esophagectomy (p=0.0004) 
and pathologic stage (p=0.0007) were determining factors. Patients who underwent an Ivor-
Lewis esophagectomy had a higher risk for death (p=0.0079), while patients who had a MIE had 
a lower risk for death (p=0.005). As the pathologic stage increases, so does risk of death, 
particularly among patients with stage II (p=0.0078) and III (p=0.0002) esophageal cancers.  
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DISCUSSION 
Esophageal resection is a complicated procedure associated with increased morbidities 
and mortality. However, there is still a debate of the impact of postoperative complications and 
its impact on prognosis and survival. We observed that patients whose postoperative periods 
were unremarkable or had minor complications (Grades 0, 1-2) had shorter lengths of stay, but 
no significant difference in survival compared with patients with major morbidities (Grades 3-5). 
This study shows that one of the most important and independent predictor of survival is 
pathologic stage, with Stage II and III tumors associated with a significantly higher risk of death. 
These results agree with those reported by Ferri and colleagues, as well as Ancona and 
colleagues at Veneto Region’s Center for Esophageal Diseases, who concluded that surgical 
complications play no role on long-term prognosis, which is entirely dependent on pathology and 
tumor characteristics3. 
Major perioperative morbidities may not have a significant effect on long-term survival 
due to the high-volume of esophagectomys performed at our institution (Figure 2). TJUH is a 
high volume institution and National Cancer Institute designated cancer center with a 
multidisciplinary approach, employing standardized clinical pathways to treating patients 
undergoing major surgeries.  Finlayson and colleagues11 reported an 8.5% higher difference in 
mortality rate, particularly among older patients, in low volume centers compared to high 
volume centers.  When comparing the trend in referrals to high volume institutions resulting in a 
concentration of major procedures in a smaller number of hospitals from 1999-2008, Finks and 
colleagues12 found a significant 11% decrease in operative mortality among esophagectomy 
patients. The experience of not only the surgical team, but also the nursing and ICU staff may 
benefit in detecting and treating postoperative complications efficiently and effectively, reducing 
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its severity.  Ghaferi and colleagues13 at the University of Michigan attributed the “failure to 
rescue” (defined as fatalities among patients with complications) in high-risk surgeries such as 
esophagectomy as a principal factor, demonstrating that although low volume centers have a 
slightly higher overall complication rate, they also have a significantly higher failure to rescue 
rate of 30.3%, compared to 13.1% in high volume centers. Advancements in addressing 
postoperative complications with procedures such as endoscopic stenting for anastomotic leak, 
which are more readily available at specialized institutions, may also contribute to a decrease in 
operative mortality14,15. What we observed in this single institution review may not be applicable 
to most hospitals.  
Furthermore, the use of the modified Clavien classification to grade postoperative 
complications in a major surgery such as esophagectomy may not be reliable. For example, 
complications such as transient confusion are graded similar to wound infections as Grade 1. 
However, it has been reported that postoperative infections do have a negative impact on long-
term survival in major gastro-intestinal cancer resections16,17. In a study conducted by Lerut and 
colleagues on the impact of postoperative complications after transthoracic esophagectomy using 
the modified Clavien classification, similar results were reported that there was no difference in 
survival curves between grades 2, 3, and 4 complications5.   Using a generalized grading system 
may dilute the real impact of specific complications in patients who undergo esophagectomy. It 
may be necessary to devise a separate and unique postoperative classification system for this 
type of major surgery.  
Analysis of the impact of specific complications found that wound infection, anastomotic 
leak, and severe respiratory morbidities (Adult Respiratory Distress Syndrome, respiratory 
failure, ventilatory support > 48 hours) did not significantly affect survival, although there was a 
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significant difference in overall survival among patients who did experience pneumonia versus 
patients who did not. These results agree with D’Annoville et al, who found that technical 
complications were associated with worse immediate hospital outcomes, but did not affect long-
term survival8. In addition, major postoperative morbidities were found to significantly increase 
patient LOS. A recent study in Bangalore, India with a study population (n=236) similar to ours, 
reported that anastomotic leak, delayed wound healing, and postoperative weight loss increased 
the risk of relapse18. This may have to do with a release in cytokines (Interleukin (IL)-6, IL-8, 
IL-1, tumor necrosis factor α) in response to stress, with the resulting inflammation associated 
with infection causing a hormonal milieu more conducive to the re-growth of cancer cells, 
known as “inflammatory oncotaxis” 19,20. Further research on whether or not the significant 
increase in patient LOS as a result of major postoperative complications has an effect on relapse-
free survival is needed. 
In conclusion, esophagectomy is a major invasive procedure that can be performed safely 
at high volume centers. Although the procedure is associated with potential postoperative 
morbidities, postoperative complication rates are reasonable when performed and cared for by an 
experienced medical team. The impact of major postoperative complications on long-term 
survival may not be as consequential as previously reported, with instead tumor characteristics at 
time of resection of most importance.             
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TABLES 
Table 1—Clavien complication scale 
Grade Definition 
0 No Complications 
1 Deviation from normal postoperative course without need for medical 
or surgical intervention 
2 Complications requiring pharmacological treatment, transfusion, or 
total parenteral nutrition 
3 Complications requiring invasive or radiological intervention: 
3a—does not require general anesthesia 
3b—requires general anesthesia 
4 Life-threatening complications requiring intensive care unit 
management: 
4a—single-organ dysfunction 
4b—multi-organ dysfunction 
5 Death 
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Table 2. Patient Characteristics  
Characteristics N % 
Total 237   
Age (mean)   62 (range 32-86)   
Gender, male 195 82.3% 
Smoker   97 40.9% 
Induction Chemoradiation 155 65.4% 
Procedure     
    Transhiatal 110 46.4% 
    Ivor-Lewis  58 24.5% 
    3-Hole  42 17.7% 
    MIE  26 11.0% 
Histology     
    Adenocarcinoma 201 84.8% 
    Squamous cell carcinoma  36 15.2% 
Tumor Location     
    Proximal 1/3    5  2.1% 
    Middle 1/3  17  7.2% 
    Distal 1/3  80 33.8% 
    GE Junction 106 44.7% 
    Stomach cardia  29  12.2% 
Pathologic Stage     
    0  39 16.5% 
  
19 
    I  51 21.5% 
    II  84 35.4% 
    III  52 21.9% 
    IV  11  4.7% 
R0 212 89.5% 
MIE—Minimally Invasive Esophagectomy 
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Table 3. Complication Grade Breakdown 
Grade n % 
0 100 42.2 
I 12 5.1 
II 53 22.4 
III 25 10.5 
IV 35 14.7 
V 12 5.1 
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Table 4. Complication Grades 
   
  None (Grade 0) Minor (Grades 1-2) Major/Mortality (Grades 3-5) p-value 
Number 99 65 72   
Age (mean) 60.1 62.2 63.1 0.16 
Gender      0.18 
    Male 76 (76.8) 56 (86.2) 62 (86.1)   
    Female 23 (23.2) 9 (13.8) 10 (13.9)   
Smoker      0.55 
    No 58 (58.6) 42 (64.6) 40 (55.6)   
    Yes 41 (41.1) 23 (35.4) 32 (44.4)   
Histology      0.91 
    Adenocarcinoma 83 (83.8) 57 (87.7) 61 (84.7)   
    Squamous cell 
carcinoma 
 
16 (16.2) 9 (12.3) 11 (15.3)   
Tumor Location      0.55 
    Proximal 1/3 2 (2.0) 1 (1.6) 2 (2.8)   
    Middle 1/3 9 (9.1) 5 (7.7) 3 (4.2)   
    Distal 1/3 34 (34.3) 19 (29.2) 27 (37.5)   
    GE Junction 38 (38.4) 35 (53.8) 32 (44.4)   
    Stomach Cardia 16 (16.2) 5 (7.7) 8 (11.1)   
Pathologic Stage      0.73 
    0 15 (15.2) 12 (18.5) 11 (15.3)   
    I 20 (20.2) 13 (20.0) 18 (25.0)   
    II 33 (33.3) 27 (41.5) 24 (33.3)   
    III 27 (27.3) 11 (16.9) 14 (19.4)   
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    IV 4 (4.0) 2 (3.1) 5 (6.9)   
Induction Therapy        
    CRT 67 (67.7) 41 (63.1) 46 (63.9) 0.80 
    pCR 15 (15.2) 9 (13.8) 9 (12.5) 0.88 
Procedure      0.16 
    Transhiatal 43 (43.4) 39 (60.0) 28 (38.9)   
    Ivor-Lewis 28 (28.3) 12 (18.5) 17 (23.6)   
    3-Hole 15 (15.2) 9 (13.8) 18 (25.0)   
    MIE 13 (13.1) 5 (7.7) 8 (11.1)   
LOS (day)        
    Mean 12.0 13.1 29 <0.0001 
    Median 10 12 20.5   
Resection      0.43 
    R0 86 (86.9) 60 (92.3) 66 (91.7)   
    R1 7 (7.1) 4 (6.2) 5 (6.9)   
    Unknown 6 (6.0) 1 (1.5) 1 (1.4)   
Mean Survival (months) 28.0 29.8 21.1 0.08 
pCR—pathologic complete response 
CRT-chemoradiation therapy 
MIE-minimally invasive esophagectomy 
LOS—length of stay 
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Table 5. Complication breakdown 
Complication n   Grade 
Respiratory Failure (requiring 
intubation) 35 (14.8)  4 
Supraventricular Arrhythmia 34 (14.3) 2 
Anastomotic Leakage 32 (13.5) 2 
Pleural Effusion (requiring 
thoracentisis or chest tube)  30 (12.7) 3a 
Wound infection 27 (11.4) 1 
Pneumonia 26 (11.0) 2 
Re-operation 25 (10.5) 3b 
Bacteremia 21 (8.9) 2 
Deep Venous Thrombosis 12 (5.1) 2 
Ventilatory Support >48 hours 18 (7.6) 2 
Adult Respiratory Distress 
Syndrome 14 (5.9) 2 
Perioperative Mortality 12 (5.1) 5 
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Table 6. Specific Complications 
 Pneumonia 
Respiratory 
Failure/ARDS/ 
Ventilatory Support Wound infection Anastomotic Leak 
  
n % n  % n % n % 
Number 26 11.0 42 17.8 27 11.4 32 14.3 
Mean LOS (days) 35.2 37.0 22.6 24.7 
p Value 0.0018 <0.0001 0.14 0.015 
Mean Survival (months) 15.0 15.8 21.5 27.2 
p Value 0.00016 0.00040 0.17 0.88 
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Table 7. Multivariable Predictors of Death after Esophagectomy 
Predictor Risk ratio 95% CI p-value 
Age     0.18 
    31-54 1.00 *   
    55-60 0.51 0.20-1.30   
    61-69 0.39 0.15-1.01   
    70-86 0.86 0.33-2.33   
Gender (female) 1.19 0.50-2.85 0.69 
Tumor Location     0.93 
    GE Junction 1.00 *   
    Proximal and Middle 1/3 0.85 0.20-3.62   
    Distal 1/3 1.17 0.53-2.61   
    Cardia 1.34 0.35-5.12   
Type of Esophagectomy     0.0004 
    Transhiatal  1.00 *   
    3-Hole 0.55 0.22-1.41   
    Ivor-Lewis 3.56 1.40-9.08   
    MIE 0.17 0.05-0.59   
Pathologic Stage     0.0007 
    0 1.00 *   
    1 1.49 0.50-4.42   
    2 3.71 1.41-9.74   
    3 11.98 3.25-44.19   
    4 6.38 0.94-43.29   
Histology (Adenocarcinoma)  1.40 0.47-4.23 0.55 
Complication Grade     0.84 
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    0 1.00 *   
    I 1.26 0.25-6.40   
    II 0.57 0.23-1.41   
    III 1.05 0.34-3.18   
    IV 0.73 0.14-3.77   
    V >999.99 <0.001->999.99  
Specific Complication       
    Pneumonia 2.19 0.59-8.11 0.24 
    Respiratory Failure/ARDS/Ventilatory Support 3.31 0.64-17.10 0.15 
    Wound Infection 1.16 0.33-4.11 0.82 
    Anastomotic Leak 1.09 0.33-3.57 0.89 
*Reference group.    
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Figure 1. Kaplan-Meier analysis of survival by complication 
grades
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Figure Legend: Kaplan-Meier survival curve demonstrating overall survival of patients with 
esophageal cancer undergoing esophagectomy broken down by types of complications where the 
green line indicates patients who experienced no postoperative complications (Clavien Grade 0), 
the blue line indicates patients who experienced minor postoperative complications (Clavien 
Grade 1 and 2), and the red line indicates patients who experienced major postoperative 
complications or mortality (Clavien Grade 3, 4, and 5). 
 
 
 
 
p = 0.095 
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Figure 2. Frequency of esophagectomies by year 
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Figure Legend: Histogram demonstrating the number of esophageal resections for curative intent 
performed at Thomas Jefferson University Hospitals from 1994-2008.  
